Updated: March 12, 2026
Olmesartan Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
- Boxed Warning: Fetal Toxicity (Pregnancy)
- Common Side Effects of Olmesartan
- Serious Side Effects: Call Your Doctor Immediately
- 1. Severe or Persistent Diarrhea (Olmesartan-Induced Enteropathy)
- 2. Hypotension (Dangerously Low Blood Pressure)
- 3. Kidney Problems
- 4. High Potassium (Hyperkalemia)
- 5. Angioedema (Swelling of Face, Throat, or Lips)
- What Olmesartan Does NOT Cause
- When to Call Your Doctor
Starting olmesartan (Benicar)? Know which side effects are common and expected, which are serious, and exactly when to call your doctor.
Olmesartan (Benicar) is generally well-tolerated — in clinical trials, its side effect profile was similar to placebo for most patients. But like all medications, it can cause side effects that range from minor inconveniences to serious medical concerns. Here's what you need to know about olmesartan's safety profile.
Boxed Warning: Fetal Toxicity (Pregnancy)
Olmesartan carries the FDA's strongest warning — a black box — about fetal toxicity. When taken during the second or third trimester of pregnancy, olmesartan can cause serious fetal harm or death, including fetal kidney failure, skeletal defects, limb deformities, and pulmonary hypoplasia. If you become pregnant while taking olmesartan, stop taking it immediately and contact your doctor right away. Women of childbearing age should use effective contraception while taking olmesartan.
Common Side Effects of Olmesartan
The most frequently reported side effects in adults taking olmesartan in clinical trials include:
Dizziness (3%): The most common reported side effect. Often worse when standing up quickly (orthostatic hypotension). Usually improves after a few weeks of treatment.
Headache: Mild headaches are common, especially early in treatment.
Back pain: Reported slightly more frequently with olmesartan than with placebo in trials.
Diarrhea: Mild diarrhea can occur, though severe persistent diarrhea is a red flag (see serious side effects below).
Fatigue: Mild tiredness, especially in the first few weeks as your body adjusts.
Upper respiratory symptoms: Runny nose, sinusitis, and bronchitis have been reported. Unlike ACE inhibitors, olmesartan does NOT cause a dry cough.
Serious Side Effects: Call Your Doctor Immediately
1. Severe or Persistent Diarrhea (Olmesartan-Induced Enteropathy)
This is unique to olmesartan among ARBs. Olmesartan-induced enteropathy (also called sprue-like enteropathy) can develop months to years after starting the medication. Symptoms include severe, chronic watery diarrhea, significant weight loss, nausea, vomiting, and electrolyte abnormalities. It can mimic celiac disease. If these symptoms occur, stop olmesartan and contact your doctor immediately — symptoms typically resolve within weeks of stopping.
2. Hypotension (Dangerously Low Blood Pressure)
Olmesartan lowers blood pressure — which is the goal — but in some patients it can drop too low, especially if you are dehydrated, taking diuretics, or on a low-salt diet. Signs include severe dizziness, lightheadedness, fainting, or feeling very weak. If this happens, lie down and contact your doctor.
3. Kidney Problems
Olmesartan can affect kidney function, particularly in patients with underlying kidney disease, heart failure, or renal artery stenosis. Signs of kidney damage include decreased urination, unusual fatigue or weakness, and swelling in legs or ankles. Your doctor will typically monitor your kidney function and potassium levels with regular blood tests.
4. High Potassium (Hyperkalemia)
Because olmesartan reduces aldosterone secretion, it can cause potassium levels to rise too high. Hyperkalemia can cause nausea, muscle weakness, tingling, chest pain, and irregular heartbeat. It's more common in patients with CKD, those taking potassium-sparing diuretics, or those using potassium salt substitutes.
5. Angioedema (Swelling of Face, Throat, or Lips)
Angioedema is a rare but potentially life-threatening reaction. Signs include sudden swelling of the face, lips, tongue, or throat, difficulty breathing, and hives. This is a medical emergency — call 911 immediately and stop taking olmesartan.
What Olmesartan Does NOT Cause
One of the key advantages of olmesartan (and all ARBs) over ACE inhibitors like lisinopril is that it does not cause a dry, persistent cough. If you were switched from an ACE inhibitor to olmesartan because of cough, you should not experience that side effect with olmesartan.
When to Call Your Doctor
You become pregnant or think you might be pregnant
You develop severe, chronic diarrhea or unexplained weight loss
You feel faint or dizzy when standing up
You notice your urine output decreasing significantly
You experience swelling in your face, lips, or throat (seek emergency care immediately)
For more safety information, see: Olmesartan Drug Interactions: What to Avoid and What to Tell Your Doctor
If you need help finding olmesartan in stock at a pharmacy near you, medfinder can help.
Frequently Asked Questions
No. Unlike ACE inhibitors (lisinopril, enalapril, ramipril), olmesartan does not cause dry cough. Olmesartan is an ARB (angiotensin receptor blocker), which works differently and does not affect the bradykinin pathway responsible for the cough seen with ACE inhibitors.
Olmesartan-induced enteropathy is a rare but serious condition unique to olmesartan. It causes severe chronic diarrhea, significant weight loss, nausea, and electrolyte imbalances — sometimes mimicking celiac disease. It can develop months or even years after starting olmesartan. Stopping the medication typically leads to resolution within weeks.
Yes, mild dizziness is the most commonly reported side effect of olmesartan (occurring in about 3% of patients in trials). It's especially common when standing quickly (orthostatic hypotension). Rise slowly from sitting or lying positions and stay hydrated. If dizziness is severe or frequent, contact your doctor.
In most patients, olmesartan has a neutral or protective effect on kidneys. However, in patients with bilateral renal artery stenosis, severe heart failure, or severe volume depletion, olmesartan can worsen kidney function. Regular monitoring of creatinine and potassium is recommended, especially early in treatment.
Yes. Olmesartan has been used for over 20 years and has a well-established long-term safety profile. Most patients tolerate it well indefinitely. Regular monitoring of blood pressure, kidney function, and electrolytes (especially potassium) is recommended to catch any issues early.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Olmesartan also looked for:
More about Olmesartan
36,837 have already found their meds with Medfinder.
Start your search today.





